Indivior Pharmaceuticals (INDV) Gross Profit (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Gross Profit of $277.0 million for Q1 2026, up 25.34% year-over-year from $221.0 million in Q1 2025, and down 5.14% quarter-over-quarter from $292.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Gross Profit (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Gross Profit history runs 3 years deep, the most recent figure standing at $277.0 million for Q1 2026.
- In Q1 2026, Gross Profit rose 25.34% year-over-year to $277.0 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 12.55% YoY), while the FY2025 annual figure was $994.0 million, up 3.87% from the prior year.
- Gross Profit for Q1 2026 stood at $277.0 million, down from $292.0 million in the prior quarter.
- The five-year high for Gross Profit was $292.0 million in Q4 2025, with the low at $220.0 million in Q2 2024.
- The 3-year median for Gross Profit is $246.0 million (2024), against an average of $247.4 million.
- The sharpest annual moves came in 2025 and 2026: Gross Profit dropped 10.16% in 2025, then gained 25.34% in 2026.
- Indivior Pharmaceuticals' Gross Profit stood at $250.0 million in 2024, then climbed by 16.8% to $292.0 million in 2025, then retreated by 5.14% to $277.0 million in 2026.
- Business Quant data shows INDV's Gross Profit at $277.0 million in Q1 2026, $292.0 million in Q4 2025, and $230.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.39 Bn | 4.16 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 294.00 Mn |
| Jun 30, 2026 | 294.00 Mn |
| Mar 31, 2026 | 277.00 Mn |
| Mar 31, 2026 | 277.00 Mn |
| Dec 31, 2025 | 292.00 Mn |
| Dec 31, 2025 | 292.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Jun 30, 2025 | 250.00 Mn |
| Jun 30, 2025 | 250.00 Mn |
| Mar 31, 2025 | 221.00 Mn |
| Mar 31, 2025 | 221.00 Mn |
| Dec 31, 2024 | 250.00 Mn |
| Dec 31, 2024 | 250.00 Mn |
| Sep 30, 2024 | 241.00 Mn |
| Sep 30, 2024 | 241.00 Mn |
| Jun 30, 2024 | 220.00 Mn |
| Jun 30, 2024 | 220.00 Mn |
| Mar 31, 2024 | 246.00 Mn |
| Mar 31, 2024 | 246.00 Mn |